T. Rowe Price Health Care ETF (TMED)
| Assets | $34.59M |
| Expense Ratio | 0.44% |
| PE Ratio | 26.87 |
| Forward PE | 23.37 |
| Shares Out | 1,000,000 |
| Dividend | $0.16 (0.47%) |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 12.66% |
| Volume | 11,135 |
| Open | 34.40 |
| Previous Close | 33.77 |
| Day's Range | 33.85 - 34.40 |
| 52-Week Low | 27.60 |
| 52-Week High | 36.72 |
| Beta | n/a |
| Holdings | 118 |
| Inception Date | Jun 11, 2025 |
About TMED
Fund Home PageThe T. Rowe Price Health Care ETF (TMED) is an exchange-traded fund. The ETF currently has 34.05m in AUM and 114 holdings. TMED is an actively managed ETF, aiming to outperform its respective sector index TMED was launched on Jun 11, 2025 and is issued by T. Rowe Price.
Top 10 Holdings
37.00% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 5.96% |
| UnitedHealth Group Incorporated | UNH | 5.08% |
| Insulet Corporation | PODD | 3.72% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 3.55% |
| Thermo Fisher Scientific Inc. | TMO | 3.41% |
| Gilead Sciences, Inc. | GILD | 3.17% |
| Elanco Animal Health Incorporated | ELAN | 3.09% |
| Intuitive Surgical, Inc. | ISRG | 3.08% |
| Agilent Technologies, Inc. | A | 3.02% |
| State Street Instl US Govt MMkt Premier | GVMXX | 2.92% |
Performance
TMED had a total return of 21.28% in the past year, including dividends. Since the fund's inception, the average annual return has been 25.57%.
News
Healthcare Stocks Face Policy Split After Midterm
Democrats won control of both the House and Senate in Tuesday's midterm elections, according to The Associated Press. The results set up a divided government for the final two years of President Donal...
T. ROWE PRICE ADDS THREE NEW TRANSPARENT SECTOR OFFERINGS TO ITS ACTIVE ETF ROSTER
BALTIMORE, June 12, 2025 /PRNewswire/ -- T. Rowe Price (NASDAQ-GS: TROW), a global investment management firm, announced today the addition of three new active transparent equity exchange-traded funds...